SAN DIEGO and ADELAIDE, Australia, June 13, 2022 /PRNewswire/ — BioCina, a leading contract development and manufacturing organization (CDMO) today announced that the company has expanded its CDMO service offering to include the manufacture of plasmid DNA (pDNA) in a new dedicated GMP…
Related Posts
Sandblasting Media Market Size to Grow by USD 2.99 Bn, Market to be Dominated by Large International Vendors – Technavio
NEW YORK, Oct. 24, 2022 /PRNewswire/ — The global sandblasting media market is highly fragmented, containing a handful of large…
Otis Appoints Anurag Maheshwari Executive Vice President & Chief Financial Officer
He succeeds Rahul Ghai to lead financial activities at Otis FARMINGTON, Conn., June 27, 2022 /PRNewswire/ — Otis Worldwide Corporation…
Next Generation Advanced Batteries Global Market Report 2022: Growing Demand for Mobile Computing Devices Lends Traction to Market Growth
DUBLIN, July 6, 2022 /PRNewswire/ — The “Next Generation Advanced Batteries – Global Market Trajectory & Analytics” report has been…
